Patents by Inventor Randy Learish

Randy Learish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APPARATUS AND METHODS FOR DELIVERY OF CELL COMPOSITIONS
    Publication number: 20240108501
    Abstract: Provided for herein is a method of cell transplantation using an injection attachment having a hub containing a plurality of cells and a cannula extending from a distal end of the hub. The method includes orienting the injection attachment such that the cannula points downwardly until the plurality of cells settle together proximate the distal end, inserting the cannula into a tissue of a subject, and injecting the volume of cells into the tissue of the subject using the injection attachment.
    Type: Application
    Filed: September 30, 2023
    Publication date: April 4, 2024
    Applicant: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Tianran LIU, Randy LEARISH, Cayla THOMPSON, Matthew STERNFELD, Michael PHILLIPS, Virginia MATTIS, Lucas CHASE, Erik BROWN
  • Reprogramming T cells and hematopoietic cells
    Patent number: 10221396
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: March 5, 2019
    Assignee: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Matthew Brown, Elizabeth Rondon Dominguez, Randy Learish, Emile Nuwaysir, Deepika Rajesh, Amanda Mack
  • REPROGRAMMING T CELLS AND HEMATOPOIETIC CELLS
    Publication number: 20170226484
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Application
    Filed: April 26, 2017
    Publication date: August 10, 2017
    Applicant: Cellular Dynamics International, Inc.
    Inventors: Matthew BROWN, Elizabeth Rondon DOMINGUEZ, Randy LEARISH, Emile NUWAYSIR, Deepika RAJESH, Amanda MACK
  • REPROGRAMMING T CELLS AND HEMATOPOIETIC CELLS
    Publication number: 20160257939
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Application
    Filed: April 27, 2016
    Publication date: September 8, 2016
    Applicant: Cellular Dynamics International, Inc.
    Inventors: Matthew BROWN, Elizabeth Rondon DOMINGUEZ, Randy LEARISH, Emile NUWAYSIR, Deepika RAJESH, Amanda MACK
  • Reprogramming T cells and hematopoietic cells
    Patent number: 9347044
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: May 24, 2016
    Assignee: Cellular Dynamics International, Inc.
    Inventors: Matthew Brown, Elizabeth Rondon Dominguez, Randy Learish, Emile Nuwaysir, Deepika Rajesh, Amanda Mack
  • REPROGRAMMING T CELLS AND HEMATOPOIETIC CELLS
    Publication number: 20140315304
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 23, 2014
    Applicant: Cellular Dynamics International, Inc.
    Inventors: Matthew BROWN, Elizabeth Rondon DOMINGUEZ, Randy LEARISH, Emile NUWAYSIR, Deepika RAJESH, Amanda MACK
  • REPROGRAMMING T CELLS AND HEMATOPOIETIC CELLS
    Publication number: 20120135525
    Abstract: Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34+ hematopoietic cells, such as human CD34+ blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.
    Type: Application
    Filed: June 4, 2010
    Publication date: May 31, 2012
    Inventors: Matthew Brown, Elizabeth Rondon Dominguez, Randy Learish, Emile Nuwaysir, Deepika Rajesh, Amanda Mack